<DOC>
	<DOCNO>NCT01217203</DOCNO>
	<brief_summary>The primary objective clinical study evaluate , patient experience first second relapse multiple myeloma , safety escalate dos IPH2101 combine lenalidomide</brief_summary>
	<brief_title>Study Safety , Anti-tumor Activity Pharmacology IPH2101 Combined With Lenalidomide Patients With Multiple Myeloma Experiencing First Second Relapse</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>1 . Signed informed consent obtain trialrelated activity 2 . Progressive disease relapse multiple myeloma ( accord IMWG definition ) one two prior therapeutic treatment regimens multiple myeloma achieve response duration least 6 month 3 . Prior therapeutic treatment regimen may include Thalidomide Lenalidomide . Regarding patient previously treat Lenalidomide , patient achieve least Partial Response duration least 6 month include . The patient must discontinue treatment due Lenalidomide intolerance . 4 . Measurable disease , indicate one following : Serum Mprotein ≥ 0.5 g/dL If Serum Protein Electrophoresis felt unreliable routine Mprotein measurement ( particularly patient IgA MM ) , quantitative immunoglobulin level accept ) . Urine BenceJones protein ≥ 200 mg/24 h Involved serum Free Light Chains ( sFLC ) level ≥ 10 mg/dl ( ≥ 100 mg/l ) provide sFLC ratio abnormal ( &lt; 0.26 &gt; 1.65 ) 5 . ECOG performance status 0 , 1 2 6 . Clinical laboratory value screen Calculated creatinine clearance ( accord MDRD ) &gt; 60 ml/min Platelet ≥ 75 x 109 /l patient &lt; 50 % BM plasma cell , ≥ 30 x 109 /l patient &gt; 50 % BM plasma cell ANC &gt; 1 x 109 /l Bilirubin level &lt; 1.5 ULN ; ALT AST &lt; 3 ULN ( grade 1 NCI ) 7 . Females childbearing potential ( FCBP ) † must negative serum urine pregnancy test sensitivity least 50 mIU/mL within 10 14 day prior within 24 hour prescribe Lenalidomide ( prescription must fill within 7 day ) must either commit continued abstinence heterosexual intercourse begin TWO acceptable method birth control , one highly effective method one additional effective method AT THE SAME TIME , least 28 day start take Lenalidomide . FCBP must also agree ongoing pregnancy test . Men must agree use latex condom sexual contact FCBP even successful vasectomy 8 . All study participant must register mandatory RevAssist® program , willing able comply requirement RevAssist® . 1 . Age &lt; 18 year &gt; 80 year 2 . Non secrete multiple myeloma non measurable disease ( &lt; 0.5 g /dL MProtein serum &lt; 200 mg urinary Mprotein / 24 h &lt; 10 mg/dl involve sFLC ) 3 . Lifethreatening condition relate MM relapse 4 . Pregnant breast feeding female . ( Lactating female must agree breast feed take Lenalidomide ) 5 . Known hypersensitivity thalidomide IMiD® . 6 . Use investigational agent within last month 7 . Treatment systemic corticosteroid ( except inhale corticosteroid ) chemotherapy ( include consolidation maintenance ) within last month ( use biphosphonates permit ) 8 . Radiotherapy within last month 9 . Primary associate amyloidosis 10 . Peripheral neuropathy grade ≥ 3 accord CTCAE NCI 11 . Abnormal cardiac status follow NYHA stage III IV congestive heart failure myocardial infarction within previous 6 month cardiac arrhythmia remain symptomatic despite treatment 12 . Current active infectious disease positive serology HIV , HCV positive Hbs Antigen 13 . History current autoimmune disease 14 . History active malignancy within past 5 year ( apart basal cell carcinoma skin , situ cervix carcinoma ) 15 . Serious concurrent uncontrolled medical disorder 16 . History allograft solid organ transplantation 17 . Any psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule 18 . Inability comply antithrombotic regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>